What are the treatment recommendations for relapsed or refractory IDH-positive acute myeloid leukemia (AML)?

Updated: Dec 05, 2018
  • Author: Karen Seiter, MD; Chief Editor: Emmanuel C Besa, MD  more...
  • Print
Answer

Answer

For relapsed or refractory IDH-positive AML

  • Enasidenib 100 mg PO once daily with or without food, until disease progression or unacceptable toxicity [32]

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!